DSIP

What is DSIP?

DSIP, short for delta sleep-inducing peptide, is a chain of nine amino acids with a molecular weight of about 849.⁸ It was isolated in 1977 by a research group in Basel, Switzerland, from the venous blood draining the brains of rabbits that had been put into deep sleep with electrical stimulation.⁵ The researchers named it after delta waves, the slow brain waves of deep sleep, because they believed it was a natural sleep-promoting factor.

That belief has not held up well. Nearly five decades later, no gene, precursor protein or receptor for DSIP has been found, and its role in sleep remains unclear.⁵

DSIP is not approved as a medicine in the US. It is sold online as a research chemical and offered by some wellness clinics for sleep, stress and chronic pain, usually as an injection before bed.

How DSIP works

The short answer is that nobody knows for sure. The original idea was that the brain releases DSIP into the blood during sleep and that giving it would bring on deep sleep. Researchers have since proposed effects on stress hormones, the body's opioid system, body temperature and daily rhythms, but none of these has been pinned down as the main mechanism.

Early work found DSIP-like material in the brain, in other organs and in the blood of several mammals, and reported effects on brain electrical activity, neurotransmitter levels, daily activity patterns, hormone levels and drug withdrawal. Its sleep effect followed a U-shaped curve for both dose and timing, so more was not better.⁸ Later, researchers found that DSIP-like immunoreactivity sits mainly in hypothalamic areas not closely tied to sleep, and that some synthetic DSIP analogs, but not DSIP itself, promoted deep sleep in rabbits and rats. They proposed that a related, still unidentified peptide may explain the activity.⁵ Whether injected DSIP reaches the brain is also uncertain. A 1983 review found that it enters the spinal fluid intact only to a slight or moderate extent.⁶ Abba Kastin, co-author of an early DSIP review, was among the first scientists to show that peptides can cross the blood-brain barrier at all.⁴

What the research shows on DSIP

The most positive human data come from the early 1980s. A 1984 summary of one investigator's work reported that two studies found better sleep after single injections given before bedtime, and that repeated injections seemed to normalize sleep structure in people with insomnia after about four doses. One case of insomnia linked to organic brain disease responded to higher doses.⁷ These were small studies from a single research program, using methods that would not meet current trial standards.

Later reviews were more cautious. A 1997 review of neuropeptides and human sleep in the journal Sleep concluded that the impact of DSIP on human sleep regulation was not yet clear.³ A 2006 review was blunter, calling the hypothesis that DSIP is a sleep factor extremely poorly documented and still weak.⁵

A 2026 review of therapeutic peptides listed DSIP among recovery-focused agents said to act on circadian regulation, while noting that clinical trials are lacking.²

In short, the evidence is a handful of small, older human studies with mixed results and no modern randomized trials. The name promises more than the research delivers. None of the studies followed people long enough to judge safety over months or years.

Studied for: Sleep research, Stress and chronic pain research.

DSIP reference data

DSIP dosage in published research

Open this in the dosage calculator ↗

How DSIP is used in practice

DSIP is sold mainly by research-chemical vendors as freeze-dried powder in vials, labeled for research use only. Users mix it with bacteriostatic water and inject it under the skin, usually shortly before bed, often in courses of a few weeks. Some wellness and anti-aging clinics have offered it, but FDA has restricted it from use in compounding. The legal status box on this page has the details.

DSIP breaks down in the blood within minutes, which makes it hard to see how a single nightly dose would have a lasting effect. User reports range from deeper sleep to no effect at all, which is consistent with the mixed research and with a strong placebo effect for sleep.

As with other research peptides, there is no independent check on what the vials contain. Products may be underdosed, contain the wrong peptide or be contaminated, and buyers have no practical way to tell.

DSIP risks and side effects

Reported side effects include headache, morning grogginess and redness or soreness at the injection site. Because DSIP may add to the effects of sedatives, combining it with alcohol, sleeping pills, benzodiazepines or opioids is a concern.

The U-shaped dose response seen in early studies means that higher doses may work less well, not better.⁸ DSIP's proposed effects on stress hormones and other hormone systems have not been studied over the long term, and there are no safety data for pregnancy or breastfeeding.

A less obvious risk is delay. Persistent poor sleep can be a sign of sleep apnea, depression, restless legs or another treatable condition. Self-treating with an unproven peptide can postpone a proper diagnosis. Unregulated injectable products also carry the usual risks of infection and contamination.

Reported side effects

Alternatives to DSIP

For chronic insomnia, cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment and is available in person, by telehealth and through digital programs. It has stronger and longer-lasting evidence than any sleep medicine.

When medication is needed, FDA-approved options include the orexin receptor antagonists suvorexant, lemborexant and daridorexant, low-dose doxepin, ramelteon and the Z-drugs such as zolpidem. Melatonin can help with circadian problems such as jet lag and delayed sleep timing. Anyone who snores loudly, wakes gasping or feels very sleepy during the day should be checked for sleep apnea.

DSIP is also marketed for stress and chronic pain. For those problems, the better-supported path is treating the underlying condition, with options ranging from physical therapy and graded exercise to talk therapy and approved medicines chosen with a clinician. Poor sleep and chronic pain often feed each other, so treating one tends to help the other.

Questions for a clinician

• What evidence applies to my situation, and at what level?
• What established alternatives should I consider first?
• What monitoring would be necessary, and how often?
• Can this be prescribed at all where I live, or only sold for research?